Table 3.
Multivariate analyses of predicting hematoma expansion in the original cohort.
Crude OR (95%CI) | P-value | Adjusteda OR (95%CI) | P-value | |
---|---|---|---|---|
>6 mL growth (N = 200) | ||||
WBC count | 0.96 (0.92–1.01) | 0.088 | 0.94 (0.90–0.99) | 0.021 |
Neutrophil count | 0.94 (0.90–0.99) | 0.008 | 0.93 (0.89–0.98) | 0.008 |
Monocyte count | 1.74 (1.10–2.78) | 0.019 | 1.45 (0.89–2.35) | 0.131 |
Lymphocyte count | 1.27 (1.09–1.49) | 0.003 | 1.09 (0.90–1.31) | 0.385 |
Eosinophil count | 7.11 (2.30–21.97) | 0.001 | 3.64 (1.04–12.7) | 0.043 |
>12.5 mL growth (N = 116) | ||||
WBC count | 0.97 (0.92–1.02) | 0.234 | 0.98 (0.92–1.04) | 0.495 |
Neutrophil count | 0.94 (0.89–0.99) | 0.023 | 0.96 (0.91–1.02) | 0.229 |
Monocyte count | 2.09 (1.26–3.48) | 0.004 | 1.98 (1.19–3.30) | 0.009 |
Lymphocyte count | 1.35 (1.13–1.61) | 0.001 | 1.14 (0.92–1.40) | 0.233 |
Eosinophil count | 11.39 (3.27–39.66) | <0.001 | 5.03 (1.13–22.3) | 0.034 |
>33% growth (N = 174) | ||||
WBC count | 0.92 (0.88–0.97) | 0.001 | 0.94 (0.89–0.99) | 0.02 |
Neutrophil count | 0.89 (0.85–0.94) | <0.001 | 0.96 (0.87–0.97) | 0.003 |
Monocyte count | 1.79 (1.12–2.88) | 0.016 | 1.62 (0.99–2.64) | 0.056 |
Lymphocyte count | 1.42 (1.21–1.67) | <0.001 | 1.18 (0.99–1.42) | 0.072 |
Eosinophil count | 19.12 (5.81–62.94) | <0.001 | 6.71 (1.73–25.9) | 0.006 |
>6 mL or 33% growth (N = 225) | ||||
WBC count | 0.95 (0.91–0.99) | 0.008 | 0.93 (0.89–0.98) | 0.004 |
Neutrophil count | 0.92 (0.88–0.96) | <0.001 | 0.92 (0.87–0.96) | <0.001 |
Monocyte count | 1.73 (1.09–2.75) | 0.019 | 1.44 (0.90–2.30) | 0.127 |
Lymphocyte count | 1.37 (1.17–1.59) | <0.001 | 1.19 (0.99–1.42) | 0.053 |
Eosinophil count | 10.38 (3.37–32.02) | <0.001 | 4.66 (1.28–17.02) | 0.02 |
>12.5 mL or 33% growth (N = 182) | ||||
WBC count | 0.93 (0.89–0.98) | 0.004 | 0.95 (0.90–0.99) | 0.034 |
Neutrophil count | 0.90 (0.86–0.95) | <0.001 | 0.93 (0.88–0.98) | 0.005 |
Monocyte count | 1.80 (1.12–2.89) | 0.015 | 1.61 (0.92–2.61) | 0.124 |
Lymphocyte count | 1.41 (1.20–1.66) | <0.001 | 1.20 (0.92–1.43) | 0.112 |
Eosinophil count | 17.07 (5.25–55.49) | <0.001 | 6.51 (1.71–24.82) | 0.006 |
OR for 103 cells increase. N represents the number of positive hematoma expansion.
Adjusted by sex, hypertension, history of cerebral hemorrhage, glasgow coma scale score, time from symptom onset to initial CT, and baseline hematoma volume. WBC, white blood cell; OR, odds ratio; CI, confidence interval; CT, computed tomography.